[Form 4] BorgWarner Inc. Insider Trading Activity
Insider sale reported: BorgWarner Inc. officer Isabelle McKenzie sold 3,000 shares of Common Stock on 09/04/2025 at $43.45 per share, leaving her with 50,255 shares beneficially owned. The Form 4 was signed by an attorney-in-fact on 09/05/2025. The filing identifies McKenzie as a Vice President and a director/officer of the company. No derivative transactions or other changes were reported.
Segnalata vendita da parte di un insider: Isabelle McKenzie, dirigente di BorgWarner Inc., ha venduto 3.000 azioni di azioni ordinarie il 04/09/2025 al prezzo di $43,45 per azione, rimanendo titolare beneficiaria di 50.255 azioni. Il Modulo 4 猫 stato firmato da un procuratore il 05/09/2025. La comunicazione identifica McKenzie come Vice Presidente e dirigente/amministratore della societ脿. Non sono state riportate transazioni su strumenti derivati n茅 altre modifiche.
Venta de insider reportada: Isabelle McKenzie, ejecutiva de BorgWarner Inc., vendi贸 3.000 acciones ordinarias el 04/09/2025 a $43,45 por acci贸n, quedando con 50.255 acciones en propiedad beneficiaria. El Formulario 4 fue firmado por un apoderado el 05/09/2025. La presentaci贸n identifica a McKenzie como Vicepresidenta y directora/funcionaria de la compa帽铆a. No se informaron transacciones con derivados ni otros cambios.
雮措秬鞛� 毵る弰 鞁犼碃: BorgWarner Inc. 鞛勳洂 Isabelle McKenzie臧� 2025-09-04鞐� 氤错喌欤� 3,000欤茧ゼ 欤茧嫻 $43.45鞐� 毵る弰頄堨溂氅�, 鞚错泟 鞁れ 氤挫湢 欤检嫕 靾橂姅 50,255欤茧 雮晞 鞛堨姷雼堧嫟. 鞏戩嫕 4電� 2025-09-05鞐� 雽�毽澑(氩曤雽�毽澑)鞐� 鞚橅暣 靹滊獏霅橃棃鞀惦媹雼�. 鞝滌稖靹滊電� McKenzie毳� 攵�靷灔 瓴� 鞚挫偓/鞛勳洂鞙茧 氇呾嫓頃橁碃 鞛堨姷雼堧嫟. 韺岇儩靸來拡 瓯半灅雮� 旮绊儉 氤�瓴� 靷暛鞚� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�.
Vente d'initi茅 signal茅e : Isabelle McKenzie, dirigeante de BorgWarner Inc., a vendu 3 000 actions ordinaires le 04/09/2025 au prix de 43,45 $ par action, ce qui la laisse d茅tentrice de 50 255 actions en propri茅t茅 b茅n茅ficiaire. Le formulaire 4 a 茅t茅 sign茅 par un mandataire le 05/09/2025. le d茅p么t identifie McKenzie comme vice鈥憄r茅sidente et dirigeante/administratrice de la soci茅t茅. Aucune transaction sur produits d茅riv茅s ni autre modification n'a 茅t茅 signal茅e.
Insider-Verkauf gemeldet: Isabelle McKenzie, F眉hrungskraft bei BorgWarner Inc., verkaufte am 04.09.2025 3.000 Stammaktien zu je $43,45 und h盲lt danach noch 50.255 Aktien als wirtschaftlich Berechtigte. Das Formular 4 wurde am 05.09.2025 von einem Bevollm盲chtigten unterzeichnet. Die Einreichung nennt McKenzie als Vice President und Vorstand/Offizier des Unternehmens. Es wurden keine Derivatgesch盲fte oder sonstige 脛nderungen gemeldet.
- None.
- Officer sale: Isabelle McKenzie sold 3,000 shares at $43.45, reducing her beneficial ownership to 50,255 shares.
Insights
TL;DR: Routine insider sale by an officer reducing holdings modestly; not clearly material to valuation.
The sale of 3,000 shares at $43.45 appears to be a straightforward disposition by a corporate officer. The filing shows remaining beneficial ownership of 50,255 shares, which indicates the transaction reduced but did not eliminate the officer's stake. There are no derivative transactions or unusual structures disclosed. Based solely on this Form 4, the sale does not reveal company performance details or material, market-moving information.
TL;DR: Disclosure meets Section 16 requirements; transaction appears routine and properly reported.
The Form 4 names Isabelle McKenzie as an officer and director who reported a sale on 09/04/2025 and the form was executed by an attorney-in-fact. The filing indicates individual reporting (single reporting person). There is no indication of Rule 10b5-1 plan checkbox or other plan-related language in the provided content. From a governance and compliance perspective, the submission contains the expected elements for an insider sale and provides transparent ownership figures.
Segnalata vendita da parte di un insider: Isabelle McKenzie, dirigente di BorgWarner Inc., ha venduto 3.000 azioni di azioni ordinarie il 04/09/2025 al prezzo di $43,45 per azione, rimanendo titolare beneficiaria di 50.255 azioni. Il Modulo 4 猫 stato firmato da un procuratore il 05/09/2025. La comunicazione identifica McKenzie come Vice Presidente e dirigente/amministratore della societ脿. Non sono state riportate transazioni su strumenti derivati n茅 altre modifiche.
Venta de insider reportada: Isabelle McKenzie, ejecutiva de BorgWarner Inc., vendi贸 3.000 acciones ordinarias el 04/09/2025 a $43,45 por acci贸n, quedando con 50.255 acciones en propiedad beneficiaria. El Formulario 4 fue firmado por un apoderado el 05/09/2025. La presentaci贸n identifica a McKenzie como Vicepresidenta y directora/funcionaria de la compa帽铆a. No se informaron transacciones con derivados ni otros cambios.
雮措秬鞛� 毵る弰 鞁犼碃: BorgWarner Inc. 鞛勳洂 Isabelle McKenzie臧� 2025-09-04鞐� 氤错喌欤� 3,000欤茧ゼ 欤茧嫻 $43.45鞐� 毵る弰頄堨溂氅�, 鞚错泟 鞁れ 氤挫湢 欤检嫕 靾橂姅 50,255欤茧 雮晞 鞛堨姷雼堧嫟. 鞏戩嫕 4電� 2025-09-05鞐� 雽�毽澑(氩曤雽�毽澑)鞐� 鞚橅暣 靹滊獏霅橃棃鞀惦媹雼�. 鞝滌稖靹滊電� McKenzie毳� 攵�靷灔 瓴� 鞚挫偓/鞛勳洂鞙茧 氇呾嫓頃橁碃 鞛堨姷雼堧嫟. 韺岇儩靸來拡 瓯半灅雮� 旮绊儉 氤�瓴� 靷暛鞚� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�.
Vente d'initi茅 signal茅e : Isabelle McKenzie, dirigeante de BorgWarner Inc., a vendu 3 000 actions ordinaires le 04/09/2025 au prix de 43,45 $ par action, ce qui la laisse d茅tentrice de 50 255 actions en propri茅t茅 b茅n茅ficiaire. Le formulaire 4 a 茅t茅 sign茅 par un mandataire le 05/09/2025. le d茅p么t identifie McKenzie comme vice鈥憄r茅sidente et dirigeante/administratrice de la soci茅t茅. Aucune transaction sur produits d茅riv茅s ni autre modification n'a 茅t茅 signal茅e.
Insider-Verkauf gemeldet: Isabelle McKenzie, F眉hrungskraft bei BorgWarner Inc., verkaufte am 04.09.2025 3.000 Stammaktien zu je $43,45 und h盲lt danach noch 50.255 Aktien als wirtschaftlich Berechtigte. Das Formular 4 wurde am 05.09.2025 von einem Bevollm盲chtigten unterzeichnet. Die Einreichung nennt McKenzie als Vice President und Vorstand/Offizier des Unternehmens. Es wurden keine Derivatgesch盲fte oder sonstige 脛nderungen gemeldet.
FAQ
What transaction did Isabelle McKenzie report on Form 4 for BWA?
How many BorgWarner (BWA) shares does Isabelle McKenzie beneficially own after the transaction?
What is Isabelle McKenzie's role at BorgWarner as stated in the filing?
When was the Form 4 signed and by whom?
Did the filing report any derivative transactions or option exercises?
